Laser Treatment After Minimized Eye Movement for Repair of Retinal Detachment

Laser Treatment After Minimized Eye Movement for Repair of Retinal Detachment

Retinal detachment repair is typically performed via three potential procedures: pneumatic retinopexy, scleral buckling, and vitrectomy. Restricting or minimizing eye movement has been previously shown to decrease subretinal fluid, and was previously more commonly performed via bilateral patching. In this study, Dr. Gregg Kokame shares a retrospective series of 39 eyes of 35 patients from June 1989 through August 2019 who underwent laser treatment and minimized eye movement (LTMEM) for retinal detachment repair. 

In select patients in the study with shallow peripheral detachments, unilateral eye patching was used to encourage compliance with minimized eye movement, which decreased subretinal fluid and then allowed subsequent indirect laser treatment with scleral depression to surround the retinal breaks. Patients were advised to avoid reading, writing, computer use, and physical activity, but allowed to watch television. The primary outcome was retinal reattachment with LTMEM alone. The secondary outcome was retinal reattachment with LTMEM and subsequent surgery. If the patient failed LTMEM alone, scleral buckling was performed. 

The average age of the 35 patients was 39 years and 11% had bilateral involvement. Refractive error was more than -6.00 diopters in 44% (17/39) eyes. All of the patients were phakic and the retinal detachment was asymptomatic in 69% (27/39) of eyes. Retinal reattachment was achieved by LTMEM alone in 79% (31/39) of eyes with 3 eyes requiring more than one laser procedure. The 8 eyes that failed LTMEM, underwent successful reattachment with scleral buckling. The average best corrected visual acuity for the 31 eyes that underwent LTMEM treatment was stable at 20/25 and the average time to resolution of subretinal fluid was 44.5 days (range 1 day to 13 months). None of the 39 eyes developed proliferative vitreoretinopathy or significant epiretinal membrane. 

Dr. Kokame’s team highlights the cost effectiveness of this treatment as it avoids a trip to the operating room. LTMEM may be an excellent option for patients with shallow, peripheral detachments as well as those patients who may decline surgery, such as the index patient in this study. Lastly, when access to the operating room is limited, such as during the recent COVID-19 pandemic, LTMEM provides us with one more option in our toolbox for the repair of retinal detachments. Caution must be taken in patient selection. Dr. Kokame’s patients were young, phakic, and had peripheral detachments. Also, be aware of the limited but potential risk for the detachment to extend into the macula. 

Details
  • Overview

    October 2021: VBS Literature Update

    Kokame GT, Yee S, Omizo JN, Villanueva L, Liu J. Laser Treatment after minimized eye movement for repair of retinal detachment. Ophthalmol Retina. 2021;5(9):939-941. doi: 10.1016/j.oret.2021.01.014. Epub 2021 Jan 30. PMID: 33529816.

    Abstract by Avni P. Finn, MD, MBA

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Understand patient selection and utility of laser treatment after minimized eye movement
    • Accreditation

      Provided by Evolve Medical Education

      Accreditation Statement

      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC and Vit Buckle Society.  Evolve Medical Education; LLC is accredited by the ACCME to provide continuing medical education for physicians.

      Credit Designation Statement
      Evolve Medical Education LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Avni P. Finn, MD, MBA

      Avni P. Finn, MD, MBA

      Assistant Professor
      Vanderbilt Eye Institute
      Nashville, TN


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:

      Avni P. Finn, MD, MBA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Apellis Pharmaceuticals, and Genentech.

      The Evolve staff and planners have no financial relationships with commercial interests.
      Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Vit Buckle Society. 

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    0.25 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free